================================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED) MAY 14, 2003
INVERNESS MEDICAL INNOVATIONS, INC.
(Exact Name of Registrant as Specified in Its Charter)
DELAWARE 001-16789 04-3565120
(State or other (Commission file (IRS Employer
jurisdiction of number) Identification No.)
incorporation)
51 SAWYER ROAD, SUITE 200, WALTHAM, MASSACHUSETTS 02453
(Address of principal executive offices)
REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE: (781) 647-3900
NOT APPLICABLE
(Former name or former address, if changed since last report)
================================================================================
ITEM 7. EXHIBITS
(c) Exhibits: The following exhibit is furnished with this
report:
EXHIBIT
NUMBER DESCRIPTION
------- ---------------------------------------------------------------
99.1 Press Release dated May 14, 2003, entitled "Inverness Medical
Innovations Announces First Quarter Results"
ITEM 9. REGULATION FD DISCLOSURE / RESULTS OF OPERATIONS AND
FINANCIAL CONDITION
In accordance with Securities and Exchange Commission Release
No. 34-47583, the following information, which is being furnished pursuant to
the requirements of Item 12, "Results of Operations and Financial Condition," is
being reported under Item 9, "Regulation FD Disclosure."
On May 14, 2003, Inverness Medical Innovations, Inc. issued a
press release entitled "Inverness Medical Innovations Announces First Quarter
Results," a copy of which is furnished with this Current Report on Form 8-K as
Exhibit 99.1. The information in this Current Report on Form 8-K shall not be
deemed to be "filed" for the purposes of Section 18 of the Securities Exchange
Act of 1934, as amended, or otherwise subject to the liabilities of that
Section, nor shall it be deemed incorporated by reference in any filing of the
Company under the Securities Act of 1933, as amended.
3
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
INVERNESS MEDICAL INNOVATIONS, INC.
BY: /s/ Duane L. James
----------------------------------------
Duane L. James
Vice President of Finance and
Treasurer
Dated: May 14, 2003
4
EXHIBIT INDEX
EXHIBIT
NUMBER DESCRIPTION
------- ---------------------------------------------------------------
99.1 Press Release dated May 14, 2003, entitled "Inverness Medical
Innovations Announces First Quarter Results"
5